Hong Zhu

6PUBLICATIONS
11CO-AUTHORS
Medical devicesCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursAtomic and molecular physicsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 20, 2024
DDX4 enhances antiviral activity of type I interferon by disrupting interaction of USP7/SOCS1 and promoting degradation of SOCS1.

Ying Miao, Tingting Zhang, Mingcheng Guan

|Nov 21, 2023
Metformin as a booster or obstacle of immunotherapy in patients with non-small cell lung cancer and diabetes mellitus.

Ming-Cheng Guan, Qian Ding, Jing Ning

|Feb 23, 2023
Hydroxymethylation and Epigenetic Drugs: New Insights into the Diagnosis and Treatment in Epigenetics of Hepatocellular Carcinoma.

Wei Ouyang, Ming-Da Wang, Wan-Yin Wang

|Sep 09, 2022
Diagnostic Performance of AFP, AFP-L3, or PIVKA-II for Hepatitis C Virus-Associated Hepatocellular Carcinoma: A Multicenter Analysis.

Siyu Liu, Liyang Sun, Lanqing Yao

|Nov 13, 2021
Fatty acid transport protein-5 (FATP5) deficiency enhances hepatocellular carcinoma progression and metastasis by reprogramming cellular energy metabolism and regulating the AMPK-mTOR signaling pathway.

Ming-Da Wang, Nan-Ya Wang, Hui-Lu Zhang

|Sep 01, 2019
The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients.

Quan Lin, Haoran Zhang, Huaxin Ding

Pageof 1

Frequent Collaborators

1 joint publications

Dong-Sheng Huang

1 joint publications

Tian Yang

1 joint publications

Timothy M Pawlik

1 joint publications

Wei Ouyang